Biliary Tract Cancer Fail Is Another Blow for Merck KGaA/GSK's Bintrafusp

Objective Response Rate Too Low For Filing

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.